Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
2021
589 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
44.57
Myrna C. B. Godoy
·
The University of Texas MD Anderson Cancer Center
Brett W. Carter
·
The University of Texas MD Anderson Cancer Center
Lorenzo Federico
·
The University of Texas MD Anderson Cancer Center
Alexandre Reuben
·
The University of Texas MD Anderson Cancer Center
M.A. Wadud Khan
·
The University of Texas MD Anderson Cancer Center
Hitoshi Dejima
·
The University of Texas MD Anderson Cancer Center
Alejandro Francisco‐Cruz
·
The University of Texas MD Anderson Cancer Center
Edwin R. Parra
·
The University of Texas MD Anderson Cancer Center
Luisa M. Solis
·
The University of Texas MD Anderson Cancer Center
Junya Fujimoto
·
The University of Texas MD Anderson Cancer Center
Hai T. Tran
·
The University of Texas MD Anderson Cancer Center
Neda Kalhor
·
The University of Texas MD Anderson Cancer Center
Frank V. Fossella
·
The University of Texas MD Anderson Cancer Center
Frank E. Mott
·
The University of Texas MD Anderson Cancer Center
Anne S. Tsao
·
The University of Texas MD Anderson Cancer Center
George Blumenschein
·
The University of Texas MD Anderson Cancer Center
Xiuning Le
·
The University of Texas MD Anderson Cancer Center
Jianjun Zhang
·
The University of Texas MD Anderson Cancer Center
Ferdinandos Skoulidis
·
The University of Texas MD Anderson Cancer Center
Jonathan M. Kurie
·
The University of Texas MD Anderson Cancer Center
Mehmet Altan
·
The University of Texas MD Anderson Cancer Center
Charles Lu
·
The University of Texas MD Anderson Cancer Center
Bonnie S. Glisson
·
The University of Texas MD Anderson Cancer Center
Lauren A. Byers
·
The University of Texas MD Anderson Cancer Center
Yasir Y. Elamin
·
The University of Texas MD Anderson Cancer Center
Reza J. Mehran
·
The University of Texas MD Anderson Cancer Center
David C. Rice
·
The University of Texas MD Anderson Cancer Center
Garrett L. Walsh
·
The University of Texas MD Anderson Cancer Center
Wayne L. Hofstetter
·
The University of Texas MD Anderson Cancer Center
Jack A. Roth
·
The University of Texas MD Anderson Cancer Center
Mara B. Antonoff
·
The University of Texas MD Anderson Cancer Center
Humam Kadara
·
The University of Texas MD Anderson Cancer Center
Cara Haymaker
·
The University of Texas MD Anderson Cancer Center
Chantale Bernatchez
·
The University of Texas MD Anderson Cancer Center
Nadim J. Ajami
·
The University of Texas MD Anderson Cancer Center
Robert R. Jenq
·
The University of Texas MD Anderson Cancer Center
Padmanee Sharma
·
The University of Texas MD Anderson Cancer Center
James P. Allison
·
The University of Texas MD Anderson Cancer Center
P. Andrew Futreal
·
The University of Texas MD Anderson Cancer Center
Jennifer A. Wargo
·
The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
·
The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
·
The University of Texas MD Anderson Cancer Center
J. Jack Lee
·
The University of Texas MD Anderson Cancer Center
Don L. Gibbons
·
The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
·
The University of Texas MD Anderson Cancer Center
John V. Heymach
·
The University of Texas MD Anderson Cancer Center
Boris Sepesi
·
The University of Texas MD Anderson Cancer Center
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial | Researchclopedia